Clinical trial

ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical…

NCT00345111 · University of Texas Southwestern Medical Center, Other · Withdrawn

Key facts

NCT number NCT00345111
Title ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)
Official title ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance With RESTOR IOL Compared With SN60WF IOL (Control Group)
Lead sponsor University of Texas Southwestern Medical Center, Other
Status Withdrawn
Phase Phase 4
Study type Interventional
Conditions Refractive Assessment
Intervention type Procedure
Interventions Clinical visual outcomes of bilateral implantation of Restore Intra Ocular Lens.
Enrollment 0
Start date Jul 1, 2005
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Jun 27, 2006
Last update posted Aug 16, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies